Korean firm Hyundai Bioscience soon to initiate global clinical development on dengue antiviral candidate
To carry out global clinical tests aimed at treating all serotypes of dengue virus infection South Korea's biotechnology company Hyundai Bioscience has completed the development of a niclosamide-based formulation to treat dengue fever with a drug …